Dr M Rafiqul Islam
Consultant Clinical Oncologist
MBBS, MRCP (UK), FRCR
English, Bengali, Urdu, Hindi
I specialise in treating colorectal, lung and Cancer of Unknown Primary (CUP) and I completed my specialist oncology training at Royal Marsden Hospital and Guy’s Hospital and obtained my diploma in oncology from the Institute of Cancer Research (ICR), in London.
I am the Clinical Oncologist in the Radiotherapy Quality Assurance group at Southend University Hospital. I am also the Lung SABR co-lead at Southend Hospital and am the principal investigator for lung and colorectal cancer trials. I took my primary medical qualification in 2001 at Dhaka University.
I was awarded the Brian Wither Travel Grant and Patricia McGregor Travel Fellowship to present my work in Florida, USA, regarding precision Radiotherapy (SABR/SBRT).
Some of the principal treatments carried out by Dr M Rafiqul Islam at Spire include:
FRCR / London / 2015
Fellow of the Royal College of Radiologists
FRCR is a degree given to Radiologists who specialise in oncology.
Member of the General Medical Council (GMC)
Member of Royal College of Radiologists (RCR)
Member of the European Society of Medical Oncologists (ESMO)
Member of the European Society for Radiotherapy & Oncology (ESTRO)
Member of MDDUS (Professional Indemnity for Drs)
The Lung SABR co-lead at Southend University Hospital
Lead oncologist to treat colorectal and anal cancer at Mid Essex Hospital Trust (MEHT)
Dean J, Welsh L, Wong K, Aleksic A, Dunne E, Islam MR, Nutting C et.al. Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Clinical Oncology. 29 (2017) 263-273
Sacco K, Muhammad A, Saleem W, Alshaker H, Monzon L, Islam MR, Pchejetski D. Leptomeningeal carcinomatosis as primary presentation of relapse in breast cancer (review). 2016 Aug;12(2):779-782.Oncology Letters.
Dean J, Welsh L, Mcquaid D, Wong K, Aleksic A, Dunne E, Islam MR, Nutting C et.al. Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk. Radiotherapy and Oncology.2016 Apr; 119(1): 166–171.Epub 2016 Feb 19.
Kunene V, Miscoria M, Pirrie S, Islam MR, Afshar M, Porfiri E. Sarcomatoid Renal Cell Carcinoma: Clinical Outcome and Survival After Treatment with Sunitinib. Clinical Genitourinary Cancer. 2014 Aug;12(4): 251–5.
Islam R, Lander F, Newbold K. Review of compliance with guidelines for risk stratification in low risk thyroid cancer at the Royal Marsden Hospital. Published as Abstract. Clinical ONCOLOGY.
Consultant Oncologist at Southend University Hospital NHS Trust and Mid Essex Hospital, Broomfield.
I enjoy spending my spare time with my wife and three children and also enjoy gardening and travelling.